Toronto - Delayed Quote CAD
Medicenna Therapeutics Corp. (MDNA.TO)
At close: October 18 at 4:00 PM EDT
Research Analysis
Earnings Per Share
Analyst Price Targets
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.06 | -0.07 | -0.24 | -0.23 |
| Low Estimate | -0.07 | -0.08 | -0.26 | -0.3 |
| High Estimate | -0.05 | -0.05 | -0.2 | -0.1 |
| Year Ago EPS | -0.05 | -0.07 | -0.37 | -0.24 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | 150k | 1.83M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 440k | 5.5M |
| Year Ago Sales | -- | -- | -- | 150k |
| Sales Growth (year/est) | -- | -- | -- | 1,120.00% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.07 | -0.07 | -0.05 | -0.06 |
| EPS Actual | -0.05 | -0.07 | -0.2 | -0.05 |
| Difference | 0.02 | 0 | -0.15 | 0.01 |
| Surprise % | 28.60% | 0.00% | -300.00% | 16.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.07 | -0.24 | -0.23 |
| 7 Days Ago | -0.06 | -0.07 | -0.24 | -0.23 |
| 30 Days Ago | -0.06 | -0.07 | -0.24 | -0.23 |
| 60 Days Ago | -0.06 | -0.07 | -0.24 | -0.23 |
| 90 Days Ago | -0.06 | -0.06 | -0.25 | -0.15 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MDNA.TO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -20.00% | -- | -- | 3.70% |
| Next Qtr. | 0.00% | -- | -- | 7.90% |
| Current Year | 35.10% | -- | -- | 2.50% |
| Next Year | 4.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Initiated | Oppenheimer: Outperform | 12/18/2020 |
| Initiated | Oppenheimer: Outperform | 12/17/2020 |
| Initiated | HC Wainwright & Co.: Buy | 9/10/2020 |
Related Tickers
ONC.TO Oncolytics Biotech Inc.
1.8500
+4.52%
MSCL.TO Satellos Bioscience Inc.
0.8000
+17.65%
APS.TO Aptose Biosciences Inc.
0.5500
+10.00%
BCT.TO BriaCell Therapeutics Corp.
1.1600
0.00%
SVA.TO Sernova Corp.
0.2650
0.00%
APLI.TO Appili Therapeutics Inc.
0.0400
+14.29%
TH.TO Theratechnologies Inc.
1.8300
+3.98%
ACOG.CN Alpha Cognition Inc.
0.6000
+15.38%
EPRX.TO Eupraxia Pharmaceuticals Inc.
3.5000
+0.86%
XRTX.V XORTX Therapeutics Inc.
2.6900
+0.75%